FDA Analyzing Lead Levels In Multivitamins, Concerned About NDIs
FDA recently tested more than 300 multivitamins for lead and will publish the results in response to pressure from Capitol Hill to follow up on a 2007 report that at least one multivitamin marketed in the U.S. contained "dangerous levels" of lead
More from Archive
Advanz Pharma would have had to show that the European Commission’s decision to revoke Ocaliva’s conditional marketing approval risked causing serious and irreparable harm, according to lawyers from Van Bael & Bellis.
This is your final call to participate in the survey to better understand our subscribers’ content and delivery needs. The deadline is 20 September.
We are conducting a survey to better understand our subscribers’ content and delivery needs. If there are any changes you’d like to see in coverage topics, article format, or the method in which you access the Pink Sheet – or if you love it how it is – now is the time to have your voice heard.
A new pilot aims to take Brazil closer to ‘digital transformation.’